[Diabetic dyslipoproteinemia: beyond LDL].

  title={[Diabetic dyslipoproteinemia: beyond LDL].},
  author={Martin Merkel},
  journal={Deutsche medizinische Wochenschrift},
  volume={134 20},
Diabetes mellitus type 2 is reaching epidemic proportions in western societies. The treatment of diabetic dyslipidemia to prevent cardiovascular disease is of increasing clinical and scientific interest. In the pathogenesis of this disease plasma triglycerides play a central role. Triglyceride rich particles by themselves are not considered atherogenic… CONTINUE READING